Advertisement
Advertisement
May 14, 2024
Rapid Medical’s Robotic Tigertriever Used in FIH Procedures to Treat Ischemic Stroke
May 14, 2024—Rapid Medical, a developer of neurovascular devices, announced the completion of the first-in-human robotic thrombectomy procedures with the company’s Tigertriever. Two patients were treated by endovascular neurosurgeon Boris Pabón, MD, at Angiosur in Medellín, Colombia.
According to Rapid Medical, Tigertriever is an endovascular thrombectomy device that adapts autonomously to the patient’s anatomy. With the press of a button, the artificial intelligence–activated Tigertriever captures the blockage with active integration. The device’s radial force is then automatically reduced to minimize trauma to the brain as it is retrieved. This function builds on the clinical results and procedure times seen with Tigertriever’s adjustability, further enhancing precision and streamlining workflow, stated the company.
“Automating stroke procedures is a significant advancement for the medical field,” commented Dr. Pabón in Rapid Medical’s press release. “Robotic clot removal achieves a level of precision that surpasses interventional capabilities. The robotic Tigertriever gives me direct insight into the vessel characteristics and senses what I cannot—truly remarkable.”
Advertisement
Advertisement
